Essex Bio-Technology Limited (HKG:1061)

Essex Bio-Technology Balance Sheet

Financials in millions HKD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	557.17	509.85	543.49	671.34	599.78
Trading Asset Securities	3.57	5.18	0.01	0.01	0.02
Cash & Short-Term Investments	560.74	515.03	543.49	671.35	599.8
Cash Growth	8.88%	-5.24%	-19.05%	11.93%	23.94%
Accounts Receivable	521.06	567.31	451.24	651.93	463.39
Other Receivables	65.24	28.11	22.49	22.34	19.86
Receivables	617.02	637.24	500.06	714.24	516.17
Inventory	84.66	75.4	93.29	99.06	165.83
Restricted Cash	-	3.41	52.94	-	-
Other Current Assets	20.89	14.21	24.2	62.73	51.06
Total Current Assets	1,283	1,245	1,214	1,547	1,333
Property, Plant & Equipment	414.21	405.86	401.11	351.9	279.75
Long-Term Investments	46.97	40.36	27.91	56.58	84.91
Goodwill	53.95	56.02	57.15	50.9	24.15
Other Intangible Assets	884.99	828.59	793.47	603.8	456.85
Long-Term Deferred Charges	256.36	240.84	200.56	188.52	145.81
Other Long-Term Assets	28.71	10.62	7.68	64.35	54.58
Total Assets	2,983	2,828	2,712	2,863	2,421
Accounts Payable	7.36	10.58	10.66	4.47	44.09
Accrued Expenses	402.4	390.07	308.41	354.81	284.87
Current Portion of Long-Term Debt	69.8	235.86	105.05	153.37	200.75
Current Portion of Leases	3.27	1.7	2.57	2.55	2.26
Current Income Taxes Payable	90.52	88.97	36.98	64.91	6.12
Other Current Liabilities	135.64	83.56	97.26	109.49	67.94
Total Current Liabilities	708.98	810.74	560.92	689.59	606.03
Long-Term Debt	95.55	36.06	382.12	406.49	354.6
Long-Term Leases	18.43	20.4	-	2.78	5.16
Long-Term Deferred Tax Liabilities	36.37	36.58	37.99	30.31	29.36
Total Liabilities	859.33	903.78	981.03	1,129	995.15
Common Stock	56.71	56.76	57.16	57.56	57.69
Additional Paid-In Capital	73.28	73.28	73.29	73.29	71.11
Retained Earnings	2,217	1,936	1,711	1,554	1,266
Comprehensive Income & Other	-223	-141.93	-109.83	49.17	31.49
Shareholders' Equity	2,124	1,924	1,731	1,734	1,426
Total Liabilities & Equity	2,983	2,828	2,712	2,863	2,421
Total Debt	187.04	294.02	489.73	565.19	562.77
Net Cash (Debt)	373.7	221	53.76	106.17	37.02
Net Cash Growth	69.09%	311.11%	-49.36%	186.75%	-67.70%
Net Cash Per Share	0.64	0.37	0.09	0.18	0.06
Filing Date Shares Outstanding	567.13	567.59	571.6	575.56	576.9
Total Common Shares Outstanding	567.13	567.59	571.6	575.56	576.9
Working Capital	574.32	434.53	653.06	857.81	726.83
Book Value Per Share	3.74	3.39	3.03	3.01	2.47
Tangible Book Value	1,185	1,039	880.75	1,080	945.18
Tangible Book Value Per Share	2.09	1.83	1.54	1.88	1.64
Buildings	114.2	116.63	117.71	127.06	122.98
Machinery	289.58	284.4	287.48	166.53	148.18
Construction In Progress	158.86	140.49	126.38	173.95	100.34

Source: S&P Global Market Intelligence. Standard template. Financial Sources.